William A. Sullivan

2013

In 2013, William A. Sullivan earned a total compensation of $968.2K as Chief Financial Officer and Treasurer at Merrimack Pharmaceuticals, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$101,441
Option Awards$568,170
Salary$284,639
Other$13,948
Total$968,198

Sullivan received $568.2K in option awards, accounting for 59% of the total pay in 2013.

Sullivan also received $101.4K in non-equity incentive plan, $284.6K in salary and $13.9K in other compensation.

Rankings

In 2013, William A. Sullivan's compensation ranked 6,770th out of 12,286 executives tracked by ExecPay. In other words, Sullivan earned more than 44.9% of executives.

ClassificationRankingPercentile
All
6,770
out of 12,286
45th
Division
Manufacturing
2,392
out of 4,612
48th
Major group
Chemicals And Allied Products
719
out of 1,462
51st
Industry group
Drugs
527
out of 1,156
54th
Industry
Pharmaceutical Preparations
419
out of 890
53rd
Source: SEC filing on March 27, 2015.

Sullivan's colleagues

We found four more compensation records of executives who worked with William A. Sullivan at Merrimack Pharmaceuticals in 2013.

2013

Robert Mulroy

Merrimack Pharmaceuticals

Chief Executive Officer

2013

Ulrik Nielsen

Merrimack Pharmaceuticals

Chief Scientific Officer

2013

William McClements

Merrimack Pharmaceuticals

Head of Corporate Operations

2013

Edward Stewart

Merrimack Pharmaceuticals

Senior Vice President and President, Merrimack Healthcare Solutions

In-depth

You may also like